Xiaodong Wang, Director at BeiGene, Ltd. (BGNE), sold 83,520 shares at $244.56 ($20.3M) on 2025-04-14, disclosed to the SEC on 2025-04-16.
Scheduled sale ($20.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $237.56 | 995 | $236K | 1.2% |
| 2 | $237.56 | 995 | $236K | 1.2% |
| 3 | $238.48 | 805 | $192K | 0.9% |
| 4 | $238.48 | 805 | $192K | 0.9% |
| 5 | $239.51 | 2,884 | $691K | 3.4% |
| 6 | $239.51 | 2,884 |
| $691K |
| 3.4% |
| 7 | $240.41 | 5,516 | $1.3M | 6.5% |
| 8 | $240.41 | 5,516 | $1.3M | 6.5% |
| 9 | $241.51 | 2,229 | $538K | 2.7% |
| 10 | $241.51 | 2,229 | $538K | 2.7% |
| 11 | $242.59 | 15,041 | $3.6M | 18.0% |
| 12 | $242.59 | 15,041 | $3.6M | 18.0% |
| 13 | $243.41 | 6,398 | $1.6M | 7.7% |
| 14 | $243.41 | 6,398 | $1.6M | 7.7% |
| 15 | $244.56 | 1,592 | $389K | 1.9% |
| 16 | $244.56 | 1,592 | $389K | 1.9% |
| 17 | $245.56 | 2,056 | $505K | 2.5% |
| 18 | $245.56 | 2,056 | $505K | 2.5% |
| 19 | $246.40 | 1,869 | $461K | 2.3% |
| 20 | $246.40 | 1,869 | $461K | 2.3% |
| 21 | $247.46 | 1,475 | $365K | 1.8% |
| 22 | $247.46 | 1,475 | $365K | 1.8% |
| 23 | $248.90 | 535 | $133K | 0.7% |
| 24 | $248.90 | 535 | $133K | 0.7% |
| 25 | $249.45 | 365 | $91K | 0.4% |
| 26 | $249.45 | 365 | $91K | 0.4% |
| Total | $242.66 avg | 83,520 | $20.3M | 100% |
| Filing → |
| ONC | SELL | 2025-06-25 | $668K | — | Filing → |
| ONC | SELL | 2025-06-12 | $21.9M | — | Filing → |
| BGNE | SELL | 2025-05-15 | $18.6M | — | Filing → |